Blood tests monitoring bone marrow function in B-cell cancers
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at whether certain blood cell tests (reticulocyte parameters) can early detect how well your bone marrow is making red blood cells in people newly diagnosed with chronic B-cell cancers. It aims to improve monitoring before standard treatments begin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be newly diagnosed with a chronic B-cell lymphoproliferative neoplasm (e.g., CLL or related lymphoma).
- You must not have received chemotherapy before.
- You must not have active bleeding.
- You must not have had a blood transfusion in the last 2 weeks.
- You must not be taking iron, folic acid, or vitamin B12 supplements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test can help track how well treatment is working in children with leukemia. It may help doctors understand the disease better and guide future care.
This study looks at simple blood test results from people newly diagnosed with acute lymphoblastic leukemia (ALL) to see if certain markers help understand the disease better.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
This study looks at two proteins on cancer cells (CD305 and CD85d) to better understand types of B-cell blood cancers. Results may help doctors tailor future treatments.
This study looks at “cell-free DNA,” meaning tiny bits of DNA found in blood, in people with mature B-cell lymphoma. It may help doctors understand the disease better and how blood tests could be used to monitor it.
This study looks at markers in the blood to understand why low red blood cell counts (anemia) can cause bleeding problems in people with certain leukemias. It may help find better ways to treat or prevent bleeding during early chemotherapy.
Hear when a new B Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.